✦ LIBER ✦

287 A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and capecitabine (C) in patients with advanced solid tumors

✍ Scribed by J.W. Valle; C. Montagut; L.C. Pronk; E.T. Jones; M. Tosca; J. Beech; B. Taylor; G. Zugmaier; P. Gascon; J. Albanell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase Ib study evaluating MNRP1685A, a

✍ Patnaik, Amita; LoRusso, Patricia M.; Messersmith, Wells A.; Papadopoulos, Kyria 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 425 KB

A phase Ib combination study of RO492909

✍ Ivan Diaz-Padilla, Hal Hirte, Amit M. Oza, Blaise A. Clarke, Brenda Cohen, Micha 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 344 KB

A phase 1b study of humanized KS-interle

✍ Joseph P Connor, Mihaela C Cristea, Nancy L Lewis, Lionel D Lewis… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 456 KB

A phase I study of bortezomib and temozo

✍ J. Portnow; P. Frankel; S. Koehler; P. Twardowski; S. Shibata; C. Martel; R. Mor 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 384 KB

A phase IB study of the pharmacokinetics

✍ Grace K. Dy; Ajit Suri; Joel M. Reid; Jeff A. Sloan; Henry C. Pitot; Steven R. A 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 388 KB

Phase 1 and dose-finding study of patrit

✍ Wakui, Hiroshi; Yamamoto, Noboru; Nakamichi, Shinji; Tamura, Yousuke; Nokihara, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 341 KB